Further Bearish Momentum? - Daily Interval - XBIO
Hello Successful Investors,
The stock (XBIO) has endured quite a concerning amount of negative (bearish) PA within the last few weeks... what is even more worrisome is there might even be greater south-side movement.. be diligent and plan accordingly prior to entering this volatile stock.
Resistance Level 3 - (13.00 - 14.15) 1.15 cent interval
Resistance Level 2 - (10.30 - 11.45) 1.15 cent interval
Resistance Level 1 - (8.75 - 9.90) 1.15 cent interval
Key Price Zone (KPZ) - (7.00 - 8.30) 1.30 cent interval
Support Level 1 - (2.90 - 4.05) 1.15 cent interval
Furthermore, the current catalyst that derived such behavior is the "$15 million of under-written stock"
Not Investment Advice. For Educational and Analytical Purposes Only. (Be Conscientious and Stick To Your Trading Plan)***
-LionGate
The stock (XBIO) has endured quite a concerning amount of negative (bearish) PA within the last few weeks... what is even more worrisome is there might even be greater south-side movement.. be diligent and plan accordingly prior to entering this volatile stock.
Resistance Level 3 - (13.00 - 14.15) 1.15 cent interval
Resistance Level 2 - (10.30 - 11.45) 1.15 cent interval
Resistance Level 1 - (8.75 - 9.90) 1.15 cent interval
Key Price Zone (KPZ) - (7.00 - 8.30) 1.30 cent interval
Support Level 1 - (2.90 - 4.05) 1.15 cent interval
Furthermore, the current catalyst that derived such behavior is the "$15 million of under-written stock"
Not Investment Advice. For Educational and Analytical Purposes Only. (Be Conscientious and Stick To Your Trading Plan)***
-LionGate
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.